Evidence map›Paper›PMID 36034734›Full record

ArticleNanoscale advances2020

Echogenic Exosomes as ultrasound contrast agents.

Jenna Osborn, Jessica E Pullan, James Froberg, Jacob Shreffler, Kara N Gange, Todd Molden, Yongki Choi, Amanda Brooks, Sanku Mallik, Kausik Sarkar

Open access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Novel Ultrasound-Responsive Amyloid Formulation.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. The Role of Exosomes in Health and Disease.International journal of molecular sciences · 2022
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Jenna OsbornMechanical and Aerospace Engineering, George Washington University, Washington DC 20052.
Jessica E PullanPharmaceutical Sciences, North Dakota State University, Fargo, ND 58105.
James FrobergPhysics, North Dakota State University, Fargo, ND 58105.
Jacob ShrefflerPharmaceutical Sciences, North Dakota State University, Fargo, ND 58105.
Kara N GangeHealth, Nutrition, and Exercise Science, North Dakota State University, Fargo, ND 58105.
Todd MoldenAnimal Science, North Dakota State University, Fargo, ND 58105.
Yongki ChoiPhysics, North Dakota State University, Fargo, ND 58105.
Amanda BrooksPharmaceutical Sciences, North Dakota State University, Fargo, ND 58105.
Sanku MallikPharmaceutical Sciences, North Dakota State University, Fargo, ND 58105.
Kausik SarkarMechanical and Aerospace Engineering, George Washington University, Washington DC 20052.
Dakota State University · USGeorge Washington University · US

Funding

Echogenic Polymersomes for Triggered Contents ReleaseR01GM114080 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI MALLIK, SANKU, SARKAR, KAUSIK · 2015 to 2023
$2.6M
NIGMS NIH HHS R01 GM114080
6 · The paper itself

Abstract

Exosomes are naturally secreted extracellular bilayer vesicles (diameter 40-130 nm), which have recently been found to play a critical role in cell-to-cell communication and biomolecule delivery. Their unique characteristics-stability, permeability, biocompatibility and low immunogenicity-have made them a prime candidate for use in delivering cancer therapeutics and other natural products. Here we present the first ever report of echogenic exosomes, which combine the benefits of the acoustic responsiveness of traditional microbubbles with the non-immunogenic and small-size morphology of exosomes. Microbubbles, although effective as ultrasound contrast agents, are restricted to intravascular usage due to their large size. In the current study, we have rendered bovine milk-derived exosomes echogenic by freeze drying them in the presence of mannitol. Ultrasound imaging and direct measurement of linear and nonlinear scattered responses were used to investigate the echogenicity and stability of the prepared exosomes. A commercial scanner registered enhancement (28.9% at 40 MHz) in the brightness of ultrasound images in presence of echogenic exosomes at 5 mg/mL. The exosomes also showed significant linear and nonlinear scattered responses-11 dB enhancement in fundamental, 8.5 dB in subharmonic and 3.5 dB in second harmonic all at 40 μg/mL concentration. Echogenic exosomes injected into the tail vein of mice and the synovial fluid of rats resulted in significantly higher brightness-as much as 300%-of the ultrasound images, showing their promise in a variety of

Indexed as

echogenicexosomesUltrasound contrast agents

Identifiers

PMID36034734
PMCPMC9410358
OpenAlexW3036014680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.